Decaire; Marc

Patent Applications and Registrations

Patent applications and USPTO patent grants for Decaire; Marc.The latest application filed is for "ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of diso".

Company Profile

2.6.8

Decaire; Marc - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Ethers, Secondary Amines And Derivatives Thereof As Modulators Of The 5-ht2a Serotonin Receptor Useful For The Treatment Of Diso App 20200247755 - Kind Code	2020-08-06
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto Grant 10,450,276 - Teegarden , et al. Oc	2019-10-22
Ethers, Secondary Amines And Derivatives Thereof As Modulators Of The 5-ht2a Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto App 20170166533 - Teegarden; Bradley ; et al.	2017-06-15
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT.sub.2A serotonin receptor useful for the treatment of disorders related thereto Grant 9,221,755 - Teegarden , et al. December 29, 2	2015-12-29
Ethers, Secondary Amines And Derivatives Thereof As Modulators Of The 5-ht 2a Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto App 20150174102 - Teegarden; Bradley ; et al.	2015-06-25
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT.sub.2A serotonin receptor useful for the treatment of disorders related thereto Grant RE45,337 - Teegarden , et al. January 13, 2	2015-01-13
Ethers, Secondary Amines And Derivatives Thereof As Modulators Of The 5-ht 2a Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto App 20140163032 - TEEGARDEN; BRADLEY ; et al.	2014-06-12
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT.sub.2A serotonin receptor useful for the treatment of disorders related thereto Grant 8,680,119 - Teegarden , et al. March 25, 2	2014-03-25
Ethers, Secondary Amines And Derivatives Thereof As Modulators Of The 5-ht2a Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto App 20120295938 - TEEGARDEN; BRADLEY ; et al.	2012-11-22
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT.sub.2A serotonin receptor useful for the treatment of disorders related thereto Grant 8,148,418 - Teegarden , et al. April 3, 2	2012-04-03
Ethers, Secondary Amines And Derivatives Thereof As Modulators Of The 5-ht2a Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto App 20090186895 - Teegarden; Bradley ; et al.	2009-07-23
5-Substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the acid receptor rup25 for the treatment of dyslipidemia and related diseases App 20070032537 - Semple; Graeme ; et al.	2007-02-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.